Request Deal Involvement
Covis Pharma completed the acquisition of the global rights of Eklira and Duaklir from AstraZeneca for $270m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Buchanan Ingersoll & Rooney
legal advisors
Sidley Austin
legal advisors
Fasken
financial advisors
Barclays
legal advisors
Paul Weiss Rifkind Wharton & Garrison
or
Principals
vendor
ASTRAZENECA PLC
target
ASTRAZENECA PLC (EKLIRA AND DUAKLIR)
bidder
COVIS PHARMA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite